Gosset research
Reports: Gastroenterology
Gosset reports matching these filters, newest first.
5 items Clear filters
Report
HCXT-2001: oral IL-23R inhibition
Inside the oral IL-23R program behind Gilead’s announced acquisition agreement: mechanism, clinical evidence and competition.
Worked example
TL1A competitive landscape
TL1A pipeline data, market dynamics, ownership charts and a downloadable spreadsheet.
- Undated
Landscape
TL1A research landscape
TL1A biology in inflammatory bowel disease, the Merck, Roche and Sanofi-Teva Phase 3 race, clinical evidence, patents and deals.
- External sample
Landscape · External · Google Sheets
Competitive landscaping: Anti-TL1A antibodies in inflammatory bowel disease (opens Google Sheets on Google Drive)
Every drug targeting a given target or modality, with detailed development status.